Sarah Boyce sold $1.2M of Avidity Biosciences (RNA)

Executed Aug 28 2025, disclosed Aug 29 2025, 1 day later.

Value, as filed

$1.2M

25,000 sh × $49.39

Executed

Aug 28 2025

the trade date, as filed

Disclosed

Aug 29 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SB Sarah Boyce President and CEO profile →

Sarah Boyce (President and CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $1.0M of RNA (14,387 sh across 2 lots, as filed), executed Jan 21.

The name

RNA RNA RNA · 61 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Sarah Boyce in RNA

RNASALE Avidity Biosciences, Inc. $1.0M
14,387 sh across 2 lots
Exec Jan 21
Filed Jan 23 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $619K
8,576 sh × $72.23
Exec Jan 7
Filed Jan 9 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $2.5M
50,000 sh × $49.95
Exec Sep 5 2025
Filed Sep 5 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $980K
31,540 sh × $31.06
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $297K
10,397 sh across 2 lots
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $1.0M
31,855 sh × $32.66
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $1.4M
32,880 sh × $44.00
Exec Sep 23 2024
Filed Sep 23 2024 · 5:30 PM ET